September catalysts: CTAP update IND confirmation; human trial start date RBL collaboration grant CRO and CDMO selection Hospital selection Confirmation IV brilacidin is ready Pre-print being made available
other possible scenarios that i don't recall IPIX mentioning -Grant money for human trials (someone correct me if i am wrong other than the Barda news back in Feb) -collaboration -partnership -sale of company or disposition of asset
hints at other possibilities -compassionate use -extra IV drug product to support potential additional COVID-19 clinical testing -Inhaler with Electrostatic Sterilizer and Use of Cationic Amphiphilic Peptides -remdesivir / brilacidin study